Department of Anesthesiology
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
Hemmings HC.  2004.  Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.
Hemmings HC.  2022.  Turning the page on 2021: an eventful year for the British Journal of Anaesthesia.. Br J Anaesth. 128(1):1-3.
Hemmings HC, Nairn AC, Elliott JI, Greengard P.  1990.  Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.. J Biol Chem. 265(33):20369-76.
Hemmings HC, Greengard P.  1989.  ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Purification and characterization of the protein from bovine caudate nucleus.. J Neurosci. 9(3):851-64.
Hemmings HC.  2009.  Sodium channels and the synaptic mechanisms of inhaled anaesthetics.. Br J Anaesth. 103(1):61-9.
Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.  2005.  Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Hemmings HC, Jevtovic-Todorovic V.  2013.  Special issue on anaesthetic neurotoxicity and neuroplasticity.. Br J Anaesth. 110 Suppl 1:i1-2.
Hemmings, Jr. HC, Egan TD.  2019.  Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application. :994.
Hemmings HC, Hunter JM.  2017.  Landmarks in UK anaesthesia.. Br J Anaesth. 119(6):1073-1074.
Hemmings HC, Nairn AC, Greengard P.  1986.  Protein kinases and phosphoproteins in the nervous system.. Res Publ Assoc Res Nerv Ment Dis. 64:47-69.
Hemmings HC, Mantz J.  2008.  Xenon and the pharmacology of fear.. Anesthesiology. 109(6):954-5.
Heerdt PM.  2004.  Anesthesia and multiorgan protein remodeling.. Anesthesiology. 101(4):1040;authorreply1040-1.
Heerdt PM.  2011.  Letter to the editor: response to Ballestero et al.. Pediatr Cardiol. 32(6):866-7.
Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D.  2000.  Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure.. Circulation. 102(22):2713-9.
Heerdt PM, Sunaga H, Savarese JJ.  2015.  Novel neuromuscular blocking drugs and antagonists.. Curr Opin Anaesthesiol. 28(4):403-10.
Heerdt PM.  1992.  Intrapulmonary Doppler for continuous measurement of cardiac output.. J Cardiothorac Vasc Anesth. 6(3):382-3.
Heerdt PM, The AHS, Markov NP.  2005.  Anesthetic-induced alteration in expression of myocardial calcium cycling proteins.. J Cardiothorac Vasc Anesth. 19(3):340-4.
Heerdt PM, Pleimann BE.  1996.  The dose-dependent effects of halothane on right ventricular contraction pattern and regional inotropy in swine.. Anesth Analg. 82(6):1152-8.
Heerdt PM, Caldwell RW.  1990.  The cardiovascular response to digoxin in conscious dogs with left atrial obstruction.. J Cardiothorac Anesth. 4(6):687-94.
Heerdt PM, Wagner CL, DeMais M, Savarese JJ.  2011.  Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles.. J Pharmacol Toxicol Methods. 64(2):111-8.
Heerdt PM, Blessios GA, Beach ML, Hogue CW.  2001.  Flow dependency of error in thermodilution measurement of cardiac output during acute tricuspid regurgitation.. J Cardiothorac Vasc Anesth. 15(2):183-7.
Heerdt PM, Heerdt ME.  1992.  The rational pharmacology of digoxin.. J Clin Anesth. 4(5):419-35.
Heerdt PM, Malhotra JK, Pan BY, Sunaga H, Savarese JJ.  2010.  Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs.. Anesthesiology. 112(4):910-6.
Heerdt PM, Pleimann BE.  1996.  Nitric oxide synthesis inhibition and right ventricular systolic function in swine.. J Cardiothorac Vasc Anesth. 10(7):909-14.
Heerdt PM, Sunaga H, Owen JS, Murrell MT, Malhotra JK, Godfrey D, Steinkamp M, Savard P, Savarese JJ, Lien CA.  2016.  Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.. Anesthesiology. 125(6):1136-1143.